Rx (Prescription Medicine)
USD $ 21.00
Sutykine 12.5mg Capsule 是一种含有活性成分 Paliperidone 的药物。Paliperidone 是一种非典型抗精神病药物，用于治疗精神分裂症和精神病性认知障碍。它通过影响大脑中某些化学物质的活性，帮助恢复多巴胺和血清素等神经递质的平衡。这可以改善精神分裂症和精神病性认知障碍患者的幻觉、妄想、思维紊乱以及缺乏动力等症状。Sutykine 通常作为综合治疗方案的一部分，可能包括心理治疗和其他药物。常规起始剂量为 12.5mg 每日一次，但您的医生会根据您的个人需求和对治疗的反应确定合适的剂量。常见的不良反应可能包括嗜睡、头晕、体重增加和运动障碍。请务必严格按照医疗提供者的处方服用 Sutykine，并与他们讨论任何疑虑或潜在的不良反应。请将 Sutykine 12.5mg Capsules 存放于室温，避免潮湿和热源。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Pack Quantity | |
| Strength |
其他品牌的 Sunitinib 12.5 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
